Sandler Capital Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-526,347
Closed -$22.7M 161
2019
Q1
$22.7M Sell
526,347
-231,916
-31% -$9.33M 1.77% 8
2018
Q4
$27.7M Buy
758,263
+15,579
+2% +$579K 2.35% 13
2018
Q3
$29.8M Buy
742,684
+40,683
+6% +$1.63M 1.51% 16
2018
Q2
$26.9M Buy
702,001
+373,525
+114% +$13.7M 2.25% 8
2018
Q1
$11.3M Buy
328,476
+249,882
+318% +$8.77M 1.37% 22
2017
Q4
$2.58M Sell
78,594
-90,949
-54% -$3.13M 0.36% 83
2017
Q3
$5.66M Sell
169,543
-71,559
-30% -$2.47M 0.71% 55
2017
Q2
$8.57M Buy
241,102
+61,176
+34% +$2.07M 0.93% 34
2017
Q1
$5.53M Buy
+179,926
New +$5.55M 0.38% 102

Other funds holding QGEN

Sandler Capital Management's QGEN Position: Q2 2019 in Review

Sandler Capital Management sold out of Qiagen (QGEN) in Q2 2019, closing a stake of 526,347 shares — an estimated $22.7M sold.

Sandler Capital Management first reported a position in QGEN in Q1 2017 and held it in 9 quarters. The position peaked at $29.8M in Q3 2018. 262 funds tracked by Wall St. Rank hold QGEN as of Q2 2019.

  • Sandler Capital Management reported no remaining Qiagen position as of Q2 2019 after selling out during the quarter.
  • Sandler Capital Management sold 526,347 Qiagen shares in Q2 2019, an estimated $22.7M.
  • Sandler Capital Management first reported a position in Qiagen in Q1 2017 and held it in 9 quarters.
  • Sandler Capital Management's Qiagen position peaked at $29.8M in Q3 2018.
  • 262 funds tracked by Wall St. Rank held Qiagen as of Q2 2019.

Based on Sandler Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.